Chemoinformaics analysis of INDOLE-3-CARBOXYALDEHYDE
| Molecular Weight | 145.161 | nRot | 1 |
| Heavy Atom Molecular Weight | 138.105 | nRig | 11 |
| Exact Molecular Weight | 145.053 | nRing | 2 |
| Solubility: LogS | -2.563 | nHRing | 1 |
| Solubility: LogP | 2.02 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 21.5996 |
| nHD | 1 | BPOL | 8.46045 |
| QED | 0.611 |
| Synth | 1.978 |
| Natural Product Likeliness | 0.095 |
| NR-PPAR-gamma | 0.04 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.008 |
| CACO-2 | -4.492 |
| MDCK | 0.00000989 |
| BBB | 0.899 |
| PPB | 0.816419 |
| VDSS | 1.172 |
| FU | 0.191707 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.45 |
| CYP2c19-inh | 0.559 |
| CYP2c19-sub | 0.285 |
| CYP2c9-inh | 0.12 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.081 |
| CYP2d6-sub | 0.782 |
| CYP3a4-inh | 0.105 |
| CYP3a4-sub | 0.182 |
| CL | 6.548 |
| T12 | 0.798 |
| hERG | 0.014 |
| Ames | 0.095 |
| ROA | 0.465 |
| SkinSen | 0.878 |
| Carcinogencity | 0.25 |
| EI | 0.994 |
| Respiratory | 0.977 |
| NR-Aromatase | 0.669 |
| Antiviral | No |
| Prediction | 0.745935 |